• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Maintenance of acquired resistance to Mycobacterium tuberculosis by L form mycobacteria macrophages

Research Project

Project/Area Number 07807063
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Respiratory organ internal medicine
Research InstitutionNara Medical University

Principal Investigator

KITA Eiji  Nara Medical University, Dept.of Bacteriology, Professor, 医学部・細菌学, 教授 (90133199)

Co-Investigator(Kenkyū-buntansha) MIZUNO Fumiko  Nara Medical University, Dept.of Bacteriology, Research Assistant, 医学部, 助手 (70271202)
Project Period (FY) 1995 – 1996
Project Status Completed (Fiscal Year 1996)
Budget Amount *help
¥1,800,000 (Direct Cost: ¥1,800,000)
Fiscal Year 1996: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1995: ¥1,200,000 (Direct Cost: ¥1,200,000)
Keywordstuberculosis / intracellular parasite / L forms / cellular immunity / BCG / 抗酸菌感染症 / マクロファージ / in situ PCR / 免疫維持機構
Research Abstract

The present study was done to prove our hypothesis that long-lived acquired resistance of humans to Mycobacterium tuberculosis is ascribed to the transformation of M.tuberculosis into L-form M.tuberculosis in macrophages localized at granulomatous lesions. To determine whether mycobacteria can transform into L forms in vivo, murine BCG infection model was used.
Results obrtained herein were as follows :
1) BCG transformed into L forms in Bcg^r mice after 60 days of infection, and treatment of infected Bcg^s miced with isoniazid (INH) induced the transformation of BCG into L forms.
2) L-form BCG was detected in mononuclear cells of granulomatous lesions in the lung by the in-situ PCR.
3) IFN-gamma was responsible for the transformation of intracellular BCG into L forms.
4) Bcg^s mice immunized with L-form BCG or colonized with L-form BCG were immune from an intravenous infection with a lethal dose of BCG.
5) Reversion of L-form BCG to parental BCG was achieved by treating L form-colonized mice with estrogen or TNF-alpha. This reversion was associated with the enhanced production of TNF-alpha and TGF-beta.
6) In L form-colonized mice, mRNAs for IL-1, IL-12 and IFN-gamma were strongly expressed after an intravenous infection with a lethal dose of BCG.
These data strongly suggest that transformation of BCG into L forms contribute to the maintenance of acquired resistance to infection with a lethal dose of BCG.Such a mechanism is possibly applied to human mycobacterial immunity which can last over a long period.

Report

(3 results)
  • 1996 Annual Research Report   Final Research Report Summary
  • 1995 Annual Research Report
  • Research Products

    (7 results)

All Other

All Publications (7 results)

  • [Publications] K. Mikasa: "Significant survivol benefit to patients with advanced non-small-cell long cancer from treatment with clarithromycin." chemotherapy. (in press). (1997)

    • Related Report
      1996 Annual Research Report
  • [Publications] 勝井則明: "気化式加湿器の微生物汚染に関する実験的研究" 空気調和・衛生工学会論文集. 61. 37-44 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] 坂本正洋: "原発性非小細胞癌患者の癌悪皮質に対するclarilhromycinの有用性に関する検討" 日本化学療法学会雑誌. 44. 879-882 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] 三笠桂一: "切除不能原発性肺癌患者に対するclarithramycinの長期投与の生存期間におよぼす有用性" 日本化学療法学会雑誌. 44. 883-889 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] 辻本正之: "経気管吸引法によるHaemophilus Inflvenzae急性呼吸器感染症の臨床的検討" 感染症学会誌. 70. 808-814 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] 喜多英二: "炎症・免疫とマクロライド" 医学ジャーナル社, 6 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] 喜多英二: "KEY WORD 1987〜98 (感染症)" 先端医学社, 2 (1996)

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1995-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi